FOLH1 and neoplasm: A study conducted by Widjaja et al. was consistent with our findings, observing that PSMA expression from pre-therapeutic PET/CT exhibited superior performance compared to PSMA-TV and TL-PSMA [25]; though in the clinic, larger tumour volumes may initially seem to be associated with lower likelihoods of treatment response.